NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PHARMACUR, S.A. DE C.V.·Registered February 13, 2020ES UNA PRUEBA DE DIAGNÓSTICO IN VITROAUTOMATIZADA PARA LA DETECCIÓN YDIFERENCIACIÓNDIRECTADELASBACTERIASYPARÁSITOS DE DIARREA HUMANA EN MUESTRAS DE HECES DE PACIENTES SINTOMÁTICOS.
IT IS AN AUTOMATED IN VITRO DIAGNOSTIC TEST FOR THE DIRECT DETECTION AND DIFFERENTIATION OF HUMAN DIARRHEA BACTERIA AND PARASITES IN STOOL SAMPLES FROM SYMPTOMATIC PATIENTS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA DETECCIÓN YDIFERECIACIÓN DE BACTERIAS YPARASITOS DE DIARREA HUMANA
- Trade Name (English)
- TEST FOR DETECTION AND DIFERECATION OF BACTERIA AND PARASITES OF HUMAN DIARRHEA
- Analysis ID
- 155R2020 SSA
- Registration Date
- February 13, 2020
- Name (Spanish)
- PHARMACUR, S.A. DE C.V.
- Name (English)
- PHARMACUR, S.A. DE C.V.
Access comprehensive regulatory information for NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII (NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 155R2020 SSA and manufactured by PHARMACUR, S.A. DE C.V.. The device was registered on February 13, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.